258 related articles for article (PubMed ID: 19643672)
1. A multicenter, outpatient, open-label study to evaluate the dosing, effectiveness, and safety of topiramate as monotherapy in the treatment of epilepsy in clinical practice.
Sankar R; Ramsay E; McKay A; Hulihan J; Wiegand F;
Epilepsy Behav; 2009 Aug; 15(4):506-12. PubMed ID: 19643672
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
3. Epilepsy outcomes in elderly treated with topiramate.
Stefan H; Hubbertz L; Peglau I; Berrouschot J; Kasper B; Schreiner A; Krimmer J; Schauble B;
Acta Neurol Scand; 2008 Sep; 118(3):164-74. PubMed ID: 18384458
[TBL] [Abstract][Full Text] [Related]
4. Topiramate in add-on therapy: results from an open-label, observational study.
Krakow K; Lengler U; Rettig K; Schreiner A; Schauble B;
Seizure; 2007 Oct; 16(7):593-600. PubMed ID: 17543544
[TBL] [Abstract][Full Text] [Related]
5. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
[TBL] [Abstract][Full Text] [Related]
6. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy.
Gilliam FG; Veloso F; Bomhof MA; Gazda SK; Biton V; Ter Bruggen JP; Neto W; Bailey C; Pledger G; Wu SC
Neurology; 2003 Jan; 60(2):196-202. PubMed ID: 12552030
[TBL] [Abstract][Full Text] [Related]
7. Topiramate titration to response: analysis of individualized therapy study (TRAITS).
Dodson WE; Kamin M; Kraut L; Olson WH; Wu SC
Ann Pharmacother; 2003 May; 37(5):615-20. PubMed ID: 12708932
[TBL] [Abstract][Full Text] [Related]
8. Topiramate monotherapy as broad-spectrum antiepileptic drug in a naturalistic clinical setting.
Guerrini R; Carpay J; Groselj J; van Oene J; Schreiner A; Lahaye M; Schwalen S;
Seizure; 2005 Sep; 14(6):371-80. PubMed ID: 15961326
[TBL] [Abstract][Full Text] [Related]
9. Topiramate versus amitriptyline in migraine prevention: a 26-week, multicenter, randomized, double-blind, double-dummy, parallel-group noninferiority trial in adult migraineurs.
Dodick DW; Freitag F; Banks J; Saper J; Xiang J; Rupnow M; Biondi D; Greenberg SJ; Hulihan J;
Clin Ther; 2009 Mar; 31(3):542-59. PubMed ID: 19393844
[TBL] [Abstract][Full Text] [Related]
10. Topiramate monotherapy in newly diagnosed epilepsy in children and adolescents.
Glauser TA; Dlugos DJ; Dodson WE; Grinspan A; Wang S; Wu SC;
J Child Neurol; 2007 Jun; 22(6):693-9. PubMed ID: 17641254
[TBL] [Abstract][Full Text] [Related]
11. Conversion from valproic acid onto topiramate in adolescents and adults with epilepsy.
Schreiner A; Stollhoff K; Ossig W; Unkelbach S; Lüer W; Bogdanow M; Schauble B;
Acta Neurol Scand; 2009 May; 119(5):304-12. PubMed ID: 19133865
[TBL] [Abstract][Full Text] [Related]
12. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center.
Bootsma HP; Coolen F; Aldenkamp AP; Arends J; Diepman L; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M
Epilepsy Behav; 2004 Jun; 5(3):380-7. PubMed ID: 15145308
[TBL] [Abstract][Full Text] [Related]
13. Topiramate monotherapy in epilepsy and migraine prevention.
Silberstein SD; Ben-Menachem E; Shank RP; Wiegand F
Clin Ther; 2005 Feb; 27(2):154-65. PubMed ID: 15811478
[TBL] [Abstract][Full Text] [Related]
14. Efficacy, tolerability, and safety of rapid initiation of topiramate versus phenytoin in patients with new-onset epilepsy: a randomized double-blind clinical trial.
Ramsay E; Faught E; Krumholz A; Naritoku D; Privitera M; Schwarzman L; Mao L; Wiegand F; Hulihan J;
Epilepsia; 2010 Oct; 51(10):1970-7. PubMed ID: 20633037
[TBL] [Abstract][Full Text] [Related]
15. Safety and effectiveness of topiramate for the management of painful diabetic peripheral neuropathy in an open-label extension study.
Donofrio PD; Raskin P; Rosenthal NR; Hewitt DJ; Jordan DM; Xiang J; Vinik AI;
Clin Ther; 2005 Sep; 27(9):1420-31. PubMed ID: 16291415
[TBL] [Abstract][Full Text] [Related]
16. Conversion from carbamazepine or oxcarbazepine to topiramate in adolescents and adults with epilepsy.
Kowalik A; Rimpau W; Adam H; Kühn F; van Oene J; Schreiner A; Bogdanow M; Schauble B;
Acta Neurol Scand; 2008 Mar; 117(3):159-66. PubMed ID: 18218062
[TBL] [Abstract][Full Text] [Related]
17. Topiramate slow dose titration: improved efficacy and tolerability.
Albsoul-Younes AM; Salem HA; Ajlouni SF; Al-Safi SA
Pediatr Neurol; 2004 Nov; 31(5):349-52. PubMed ID: 15519117
[TBL] [Abstract][Full Text] [Related]
18. Topiramate in migraine prevention: results of a large controlled trial.
Silberstein SD; Neto W; Schmitt J; Jacobs D;
Arch Neurol; 2004 Apr; 61(4):490-5. PubMed ID: 15096395
[TBL] [Abstract][Full Text] [Related]
19. Long-term assessment of topiramate for epilepsy: an open-label, single-arm, multicentre, prospective study in a naturalistic setting.
Hufnagel A; Kowalik A; Rettig K; Schreiner A; Schäuble B;
Clin Drug Investig; 2011 Nov; 31(11):779-90. PubMed ID: 21967069
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic-pharmacodynamic assessment of topiramate dosing regimens for children with epilepsy 2 to <10 years of age.
Girgis IG; Nandy P; Nye JS; Ford L; Mohanty S; Wang S; Ochalski S; Eerdekens M; Cox E
Epilepsia; 2010 Oct; 51(10):1954-62. PubMed ID: 20880232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
